Marine Exopolysaccharide Complexed with Scandium Aimed as Theranostic Agents

Background: Exopolysaccharide (EPS) derivatives, produced by Alteromonas infernus bacterium, showed anti-metastatic properties. They may represent a new class of ligands to be combined with theranostic radionuclides, such as 47Sc/44Sc. The goal of this work was to investigate the feasibility of such coupling. (2) Methods: EPSs, as well as heparin used as a drug reference, were characterized in terms of molar mass and dispersity using Asymmetrical Flow Field-Flow Fractionation coupled to Multi-Angle Light Scattering (AF4-MALS). The intrinsic viscosity of EPSs at different ionic strengths were measured in order to establish the conformation. To determine the stability constants of Sc with EPS and heparin, a Free-ion selective radiotracer extraction (FISRE) method has been used. (3) Results: AF4-MALS showed that radical depolymerization produces monodisperse EPSs, suitable for therapeutic use. EPS conformation exhibited a lower hydrodynamic volume for the highest ionic strengths. The resulting random-coiled conformation could affect the complexation with metal for high concentration. The LogK of Sc-EPS complexes have been determined and showing that they are comparable to the Sc-Hep. (4) Conclusions: EPSs are very promising to be coupled with the theranostic pair of scandium for Nuclear Medicine.

Keyword(s)

exopolysaccharides, scandium, theranostic, characterization, complexation

Full Text

FilePagesSizeAccess
Publisher's official version
23827 Ko
How to cite
Mazza Mattia, Alliot Cyrille, Sinquin Corinne, Colliec-Jouault Sylvia, Reiller Pascal E., Huclier-Markai Sandrine (2021). Marine Exopolysaccharide Complexed with Scandium Aimed as Theranostic Agents. Molecules. 26 (4). 1143 (23p.). https://doi.org/10.3390/molecules26041143, https://archimer.ifremer.fr/doc/00681/79332/

Copy this text